Screening and monitoring for diabetic retinopathy

Screening and monitoring for diabetic retinopathy is vital for all patients with diabetes because retinopathy can be extensive without any obvious symptoms. It can progress without any visual loss or visual changes until it is severe.

Screening starts at diagnosis for patients with type 2 diabetes, and 2 to 5 years after diagnosis of type 1 diabetes (after age 11 years), unless the patient has comorbidities that put them at higher risk. Factors that increase risk or are associated with retinopathy include chronic hyperglycaemia, longer diabetes duration, diabetic kidney disease, elevated blood pressure, dyslipidaemia and tobacco smoking. Advice on frequency of screening for and monitoring of retinopathy is outlined in Recommended frequency of screening for and monitoring of chronic complications and conditions associated with type 1 diabetes for type 1 diabetes and Recommended frequency of screening for and monitoring of chronic complications and conditions associated with type 2 diabetes for type 2 diabetes.

Patients with diabetes have an increased risk of developing cataracts and glaucoma.